FMW
Farr Miller & Washington Portfolio holdings
AUM
$1.53B
This Quarter Return
+7.63%
1 Year Return
+32.74%
3 Year Return
+62.39%
5 Year Return
+125.83%
10 Year Return
–
AUM
$1.42B
AUM Growth
+$1.42B
(+8.5%)
Cap. Flow
+$24.2M
Cap. Flow
% of AUM
1.7%
Top 10 Holdings %
Top 10 Hldgs %
38.25%
Holding
191
New
15
Increased
96
Reduced
45
Closed
6
Top Buys
| 1 |
Visa
V
|
$22.2M |
| 2 |
RTX Corp
RTX
|
$14.5M |
| 3 |
Mondelez International
MDLZ
|
$2.01M |
| 4 |
Procter & Gamble
PG
|
$1.9M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
$1.88M |
Top Sells
| 1 |
Cognizant
CTSH
|
$23.5M |
| 2 |
Verizon
VZ
|
$4.18M |
| 3 |
Weyerhaeuser
WY
|
$2.05M |
| 4 |
IBM
IBM
|
$1.8M |
| 5 |
Microsoft
MSFT
|
$1.12M |
Sector Composition
| 1 | Healthcare | 20.95% |
| 2 | Industrials | 15.2% |
| 3 | Technology | 13.78% |
| 4 | Financials | 11.42% |
| 5 | Communication Services | 11.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Vanguard Large-Cap ETF
VV
$44.3B
| $212K | 0.01% |
1,143
-137
| -11% | -$25.4K |
|
177
Idexx Laboratories
IDXX
$50.7B
| $209K | 0.01% |
428
+2
| +0.5% | +$977 |
|
178
Northern Trust
NTRS
$24.7B
| $209K | 0.01% |
+1,986
| New | +$209K |
|
179
Novartis
NVS
$248B
| $208K | 0.01% |
2,439
| – | – |
|
180
GSK
GSK
$79.3B
| $207K | 0.01% |
4,638
| – | – |
|
181
iShares Select Dividend ETF
DVY
$20.6B
| $206K | 0.01% |
1,807
-568
| -24% | -$64.8K |
|
182
Viatris
VTRS
$12.3B
| $193K | 0.01% |
13,810
+286
| +2% | +$4K |
|
183
Spirit AeroSystems
SPR
$4.85B
| – | – |
-8,579
| Closed | -$335K |
|
184
Kinross Gold
KGC
$26.6B
| – | – |
-16,445
| Closed | -$121K |
|
185
Mind CTI
MNDO
$24.1M
| – | – |
-77,287
| Closed | -$200K |
|
186
SiriusXM
SIRI
$7.78B
| – | – |
-2,000
| Closed | -$127K |
|
187
Vanguard FTSE Developed Markets ETF
VEA
$169B
| – | – |
-5,502
| Closed | -$260K |
|
|
188
Weyerhaeuser
WY
$17.9B
| – | – |
-61,191
| Closed | -$2.05M |
|